Featured Research

from universities, journals, and other organizations

Pivotal immune cell in Type 1 diabetes in humans identified

Date:
January 15, 2012
Source:
La Jolla Institute for Allergy and Immunology
Summary:
Researchers have demonstrataed -- for the first time in human tissues -- the specific immune system T cells which trigger the destruction of Type 1 diabetes in the pancreas. The finding is an important advance that verifies in humans several important disease characteristics shown in mouse studies and provides a key focal point for interrupting the disease process.

Researchers at the La Jolla Institute for Allergy & Immunology have proven -- for the first time in human tissues -- the specific immune system T cells which trigger the destruction of type 1 diabetes in the pancreas. The finding is an important advance that verifies in humans several important disease characteristics shown in mouse studies and provides a key focal point for interrupting the disease process.

"This study marks the first time that the presence of beta cell-reactive T cells has been directly proven in pancreas tissues from type 1 diabetes patients," explained Ken Coppieters, Ph.D., first author on the study published online January 2nd in the in the Journal of Experimental Medicine. "Previously, it was only known in plastic dishes or mouse models. What is unique about this study is the use of human tissue."

Human pancreatic tissue for the studies was provided through a collaborative type 1 diabetes research consortium funded by JDRF, a leading charitable supporter of type 1 diabetes research. The JDRF's Network for Pancreatic Organ Donors with Diabetes (nPOD) provides rare and difficult to obtain pancreatic tissues to carefully selected research organizations worldwide. Participating institutions are chosen based on their history and quality of type 1 diabetes research.

"Mice represent an excellent model for disease, but eventually it is important to confirm in human tissues the things that you learn in mice," said Matthias von Herrath, M.D., a well-known type 1 diabetes researcher, who led the scientific team. "The use of this tissue from the nPOD consortium was critical to our ability to prove which T cells are most important in destroying beta cells in humans, which leads to type 1 diabetes, and where these cells are located in the pancreas."

The study was published in a paper entitled, "Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients." Dr. von Herrath was senior author.

Previously, the research community had assumed, based on lab and mouse studies, that T cells -- the body's soldier-like attack cells -- recognize and react against certain molecular structures on the beta cells and then kill the beta cells. The La Jolla Institute study confirmed this occurrence and showed the T cells location in the islets of the pancreas, which house the beta cells. The team is also is the first to identify the specific T cells -- CD8 -- as being key in the destruction of beta cells. This destruction eventually leads to the beta cell's inability to produce insulin, the hallmark of type 1 diabetes.

Dr. Coppieters, formerly of the La Jolla Institute and now at Ghent University, Belgium, said the study serves to clarify an important step in the type 1 diabetes process in humans. "It points to the CD8 T cells as being one of the most important cells that we should focus on to stop type 1 diabetes progression, once it is already underway."

In addition, the research team identified the places on the beta cells that trigger the T cell attack. T cells come in several different types and, in type 1 diabetes, react against a variety of substances produced within the body.

"Knowing which pieces of the molecules the T cells react against is a crucial prerequisite to design therapies that attempt to restore balance within the immune system," said Dr. Coppieters.


Story Source:

The above story is based on materials provided by La Jolla Institute for Allergy and Immunology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Coppieters et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. Journal of Experimental Medicine, January 2, 2012

Cite This Page:

La Jolla Institute for Allergy and Immunology. "Pivotal immune cell in Type 1 diabetes in humans identified." ScienceDaily. ScienceDaily, 15 January 2012. <www.sciencedaily.com/releases/2012/01/120112095851.htm>.
La Jolla Institute for Allergy and Immunology. (2012, January 15). Pivotal immune cell in Type 1 diabetes in humans identified. ScienceDaily. Retrieved August 30, 2014 from www.sciencedaily.com/releases/2012/01/120112095851.htm
La Jolla Institute for Allergy and Immunology. "Pivotal immune cell in Type 1 diabetes in humans identified." ScienceDaily. www.sciencedaily.com/releases/2012/01/120112095851.htm (accessed August 30, 2014).

Share This




More Health & Medicine News

Saturday, August 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com
Killer Amoeba Found in Louisiana Water System

Killer Amoeba Found in Louisiana Water System

AP (Aug. 28, 2014) State health officials say testing has confirmed the presence of a killer amoeba in a water system serving three St. John the Baptist Parish towns. (Aug. 28) Video provided by AP
Powered by NewsLook.com
Who Could Be Burnt by WHO's E-Cigs Move?

Who Could Be Burnt by WHO's E-Cigs Move?

Reuters - Business Video Online (Aug. 28, 2014) The World Health Organisation has called for the regulation of electronic cigarettes as both tobacco and medical products. Ciara Lee looks at the impact of the move on the tobacco industry. Video provided by Reuters
Powered by NewsLook.com
CDC Director On Ebola Outbreak: 'It's Worse Than I Feared'

CDC Director On Ebola Outbreak: 'It's Worse Than I Feared'

Newsy (Aug. 28, 2014) CDC director Tom Frieden says the Ebola outbreak is even worse than he feared. But he also said there's still hope to contain it. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins